http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103285017-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 |
| filingDate | 2013-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103285017-B |
| titleOfInvention | Compound isosorbide mononitrate aspirin sustained-release capsule preparation and preparation method |
| abstract | A kind of compound isosorbide mononitrate aspirin sustained-release capsule preparation, it is characterized in that, described compound preparation comprises Slow-release isosorbide mononitrate preparation and aspirin enteric-coated preparation, wherein said Slow-release isosorbide mononitrate preparation is containing isosorbide mononitrate 40-80 components by weight percent, and described aspirin enteric-coated preparation is containing aspirin 50-90 components by weight percent.Described Slow-release isosorbide mononitrate preparation comprises the fast release micropill of 30% isosorbide mononitrate dose and the slow-release micro-pill of 70% isosorbide mononitrate dose.Present invention also offers the preparation method of compound capsule.The present invention is conducive to the untoward reaction that raising curative effect causes the stimulation of gastric mucosa with minimizing aspirin, and isosorbide mononitrate also can reach the requirement of Stable Release under one's belt simultaneously. |
| priorityDate | 2013-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.